Navigation Links
New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
Date:11/4/2011

PRINCETON, N.J., Nov. 4, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) and Bristol-Myers Squibb Company (NYSE: BMY) announced today the addition of four treatment arms to the ongoing Phase IIa trial evaluating the combination of Pharmasset's PSI-7977, a nucleotide polymerase inhibitor, and Bristol-Myers Squibb Company's daclatasvir (BMS-790052), an investigational NS5A replication complex inhibitor, for the treatment of chronic hepatitis C (HCV).  This trial is the result of a clinical collaboration agreement between Pharmasset and Bristol-Myers Squibb announced in January 2011.

"Recent data from Pharmasset's ELECTRON trial as well as other all-oral DAA combination studies have demonstrated the potential of 12 week treatment regimens," stated William Symonds, Pharmasset's Senior Vice President of Clinical Pharmacology and Translational Medicine. "This study will evaluate whether the potent antiviral activity and high barrier to resistance seen in Phase II studies of PSI-7977 may enable shorter treatment durations with an interferon-free regimen than the current standard of care."

"Hepatitis C is a rapidly evolving field of research.  As the science evolves, we are evolving our clinical development programs to continue to drive advances in HCV research," said Brian Daniels, senior vice president, Development, Bristol-Myers Squibb.  "Shorter duration, all-oral therapy and effective treatment options for patients who have failed approved triple therapy regimens are clear unmet medical needs in HCV.  With this study, we aim to understand the potential for daclatasvir to help address these needs, as part of a novel combination treatment regimen."

About the Trial

T
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
2. Neuroscience Researcher Has Positive Message for International Alzheimers Awareness Week, July 6 - 12: Even Though World Economy is Declining, Alzheimers Research is Advancing
3. Timberline Knolls Rejoices in Recovery During National Eating Disorder Awareness Week, Feb. 20-26
4. Roche Diabetes Care Celebrates Second Annual Infusion Site Awareness Week, Aug. 29-Sept. 4
5. Experis Recognizes National Healthcare IT Week, Provides Tips for ICD-10 Assessment Decision
6. Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
7. Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... to data released today by the Centers for Medicare ... D premium is expected to remain stable at $32, ... Pharmaceutical Care Management Association (PCMA) said. "The ... spot in American health care. By offering an abundance ... edge, cost-saving tools like pharmacy networks and home delivery ...
(Date:7/31/2014)... , July 31, 2014  Sorrento Therapeutics, Inc. (NASDAQ: ... Mr. Amar Singh , Chief Business Officer and Executive ... natural causes on July 30. "Sorrento is deeply ... and colleague. Our immediate thoughts go to Amar,s family and ... Chief Executive Officer. Mr. Singh joined Sorrento ...
(Date:7/31/2014)... -- STAAR Surgical Company (NASDAQ: STAA ) ... and delivery systems for the eye today reported revenue ... $20.0 million, a 10% increase over $18.2 million reported ... currency basis, revenues grew 11% during the second quarter ... The effect of foreign currency exchange reduced sales by ...
Breaking Medicine Technology:Sorrento Announces the Unexpected Death of its Chief Business Officer 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31
... Life Technologies Corporation (NASDAQ: LIFE ) ... with GlaxoSmithKline Biologicals S.A. (GSK) to develop a diagnostic ... GSK candidate cancer immunotherapy. Specifically, Life will develop a ... candidate designed to identify patients likely to benefit from ...
... (Cayman) Inc. (NYSE: WX ), a leading ... operations in China and the United States, today announced ... quarter of 2011 after the New York Stock Exchange ... Friday morning, November 11, 2011 Shanghai time). The earnings ...
Cached Medicine Technology:Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 2Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 3Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 4WuXi PharmaTech Schedules Third-Quarter 2011 Earnings Release 2
(Date:7/31/2014)... On October 10, at the Palmer ... Applied Research Foundation, in collaboration with the University ... mesothelioma conference geared to patients and ... to mesothelioma and presented by local and regional ... include imaging, genetics, first-line therapies, surgery, chemotherapy, radiation ...
(Date:7/31/2014)... GA (PRWEB) July 31, 2014 Developer ... camera on its Ponce City Market project in ... historic Sears, Roebuck & Company building into best-in-class office, ... completion, OxBlue reviewed Jamestown’s experience with their construction webcam ... , Jamestown wanted a construction camera ...
(Date:7/31/2014)... The 2013 PolyU TSI hit a record high ... 2012. The index measures inbound tourists’ satisfaction levels ... an overall index. The 2013 index indicates that ... Kong over time. , The index shows that ... Hong Kong are attractions (79.27) and transportation (78.58). ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Leelanau Peninsula’s newest ... July 3, 2014 at 7788 East Horn Road in Lake ... Wine Trail , Aurora Cellars is the 25th winery along ... including the popular wine tour events, making its trail event ... 6-7, 2014. , Owners David and Faye Mathia opened ...
(Date:7/31/2014)... Orem, Utah (PRWEB) July 31, 2014 Hoping ... supplement brand they can trust , NutriGold is ready ... been set up to make taking advantage of this offer ... Kahn, Director of Research and Development at NutriGold, "We know ... are entrusting us with their most precious asset: their own ...
Breaking Medicine News(10 mins):Health News:October Events: Regional Conference on Mesothelioma in Chicago 2Health News:October Events: Regional Conference on Mesothelioma in Chicago 3Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3Health News:Aurora Cellars Joins the Leelanau Peninsula Wine Trail 2Health News:NutriGold Launches Product Samples Page for its Supplements 2Health News:NutriGold Launches Product Samples Page for its Supplements 3
... NEW YORK, July 1 Prostate cancer is the ... caught early, prostate cancer,has a 90% cure rate., ... and,Minimally Invasive Surgery, Department of Urology, at Mount Sinai ... to wait until there are,warning signs, because by then ...
... Meet Aggressive Hospital Opening Schedule; Eases Ongoing IT Development ... ... RIOJA, Spain, July 1 TIBCO Software Inc.,(Nasdaq: TIBX ) ... Rioja has deployed its real-time integration,infrastructure. The project at Servicio Riojano ...
... Growth In All Existing Markets -, LONG ... Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider ... surpassed,67,000 beds served, a five percent increase over ... all five of its institutional facilities,including Long Beach, ...
... July 1 ETHICON, Inc., a Johnson &,Johnson ... offer from One Equity Partners to acquire the ... process to,prepare for the divestiture of the Professional ... process and receipt of the offer has decided ...
... Healthcare Underwriters Group Mutual of Ohio (HUOH), the only medical liability ... by Ohio physicians, announced today that it will make its first ... Board of Directors after the company achieved outstanding loss results for ... single paid loss. , ...
... support organization for families going through the natural ... is hosting its 31st national conference July 18-20 ... and grandparents, as well as professionals who provide ... include well-known speakers, more than 100 workshops covering ...
Cached Medicine News:Health News:With Prostate Cancer: Waiting for Symptoms Is Not an Option 2Health News:Rioja Hospital Uses TIBCO Software to Improve Customer Care and Streamline Operations 2Health News:Chem Rx Corporation Surpasses 67,000 Beds Served 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 3Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 4Health News: Great Doctors Produce Great Results (Healthcare Underwriters Group Mutual of Ohio Pays A Cash Dividend): -- Healthcare Underwriters Group Mutual of Ohio Pays Its First Cash Distribution to Its Insured Owners 2Health News:Families Mourning Children Travel to Nashville for July Compassionate Friends National Conference 2
Unmatched versatility for hemostasis wherever needed. Can be applied to suit your needs....
Portable, easy to align, automatic measurement, automatic fogging. Accurate and dependable readings. Infrared printer communication. Rechargeable battery. Integrates with the TRS-2100 and EPIC-2100 r...
... Tango ophthalmic laser system provides two lasers ... and a photodisruptor for posterior capsulotomy and ... Nd:YAG producing pulsed 532 nm light. The ... nm. The appropriate laser can be easily ...
Thin and smooth jaws, designed to enter trough 3 mm incision, cross action....
Medicine Products: